Telbus-H Tablets

TELMISARTAN 

• It shows equal benefits in composite endpoint of CV death, MI, Stroke, CHF hopitalization & organ protection 
• Has lower rates of cough & angioedema, Hence Lesser side effects & better tolerated than ramipril 

AMLODIPINE 

• Gradual onset of therapeutic action 
• No fluctuation in B.P. 
• Control during vulnerable morning hours 
• Spares sudden cardiac episodes of myocardial ischemia 

Usage

• Patients with mild to severe hypertension 
• Diabetic Hypertensives Elderly Hypertensives